Production (Stage)
Zai Lab Limited
ZLAB
$31.32
-$1.18-3.63%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 43.72% | 49.59% | 35.01% | 28.16% | 25.94% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 43.72% | 49.59% | 35.01% | 28.16% | 25.94% |
Cost of Revenue | 8.16% | 11.67% | 26.47% | 2.83% | -25.07% |
Gross Profit | 506.97% | 692.54% | 99.25% | 394.14% | 116.01% |
SG&A Expenses | 1.62% | 6.08% | 10.24% | 11.55% | 9.00% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.69% | 5.88% | 13.14% | 4.63% | 6.91% |
Operating Income | 28.95% | 25.08% | 3.34% | 10.38% | 4.25% |
Income Before Tax | 25.63% | 23.17% | 10.01% | 24.09% | 17.34% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 25.63% | 23.17% | 10.01% | 24.09% | 17.34% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 25.63% | 23.17% | 10.01% | 24.09% | 17.34% |
EBIT | 28.95% | 25.08% | 3.34% | 10.38% | 4.25% |
EBITDA | 30.48% | 26.47% | 4.18% | 10.96% | 4.48% |
EPS Basic | 28.83% | 25.11% | 10.94% | 24.92% | 18.15% |
Normalized Basic EPS | 35.82% | 29.61% | 14.53% | 27.45% | 13.65% |
EPS Diluted | 28.83% | 25.11% | 10.94% | 24.92% | 18.15% |
Normalized Diluted EPS | 35.82% | 29.61% | 14.53% | 27.45% | 13.65% |
Average Basic Shares Outstanding | 4.85% | 2.38% | 1.20% | 1.12% | 1.02% |
Average Diluted Shares Outstanding | 4.85% | 2.38% | 1.20% | 1.12% | 1.02% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |